Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - STOCK-BASED COMPENSATION
Stock-based Compensation TRVI - Trevi Therapeutics, Inc.
3.59 M
LAST VALUE
24.17%
2 YEAR CAGR
26.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR